If the FDA gives its permission, ophthalmologists may be on their way to stopping and even reversing age-related macular degeneration with an implantable mini-telescope. Developed by VisionCare Ophthalmic Technologies, it works with the eye’s cornea making the retinal image larger. The scope consists of a 4.4 x 3.6 mm glass cylinder with wide-angle micro-optics to produce telephoto images. Currently about 1.75 million Americans suffer from the disease and the prediction by NIH’s National Eye Institute is that it will almost double by 2020 because of all the baby boomers that will be aging in the next 2 decades.
Read More | Scientific American